Procter & Gamble

P&G pulls in $84.3B a year, yet the market still pays 23.9x earnings for it.

If you own PG, your money is parked in a soap-and-diaper machine that sells $84.3B a year.

pg

consumer large cap updated mar 13, 2026
$163.51
market cap ~$380B · 52-week range $138–$167
xvary composite: 84 / 100 · above average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
P&G sells everyday essentials like diapers, detergent, shampoo, and toothpaste to households around the world.
how it gets paid
Last year Procter & Gamble made $84.3B in revenue. Fabric/Home Care was the main engine at $30.3B, or 36% of sales.
why it's growing
Revenue grew 0.3% last year. The $1.88 EPS print mattered because it missed the $1.95 consensus by $0.07.
what just happened
P&G posted $1.88 EPS, missing Yahoo's $1.95 bar even though some coverage had $1.86.
At a glance
A++ balance sheet — fortress balance sheet — as safe as it gets
100/100 earnings predictability — you can trust these numbers
23.9x trailing p/e — priced about right
2.6% dividend yield — cash in your pocket every quarter
20.0% return on capital — nothing to write home about
xvary composite: 84/100 — above average
What they do
P&G sells everyday essentials like diapers, detergent, shampoo, and toothpaste to households around the world.
P&G has five big buckets: Fabric/Home Care at 36% of sales and Baby/Feminine/Family Care at 24%. That means your Tide and Pampers habit keeps sending cash back to Cincinnati. The punchline is 100 earnings predictability and a 0.65 beta, so this stock acts calmer than the market.
consumer mega-cap staples pricing-power dividend
How they make money
$84.3B annual revenue · their business grew +0.3% last year
Fabric/Home Care
$30.3B
Baby/Feminine/Family Care
$20.2B
Beauty
$15.2B
Health Care
$11.8B
Grooming
$6.8B
The products that matter
laundry and home cleaning
Fabric & Home Care
$16.1B · 36% of sales
it is the biggest segment at $16.1B, or 36% of company sales. when investors call PG a staples stock, this is what they mean.
36% of sales
diapers and paper products
Baby, Feminine & Family Care
$10.7B · 24% of sales
this $10.7B segment contributes 24% of revenue. diapers and tissue are not optional purchases, which is why this bucket matters in a slowdown.
defensive demand
hair and skin care
Beauty
$8.0B · 18% of sales
Beauty is an $8.0B business, or 18% of sales. it is also one of the first places shoppers can trade down if the consumer gets tight.
watch the consumer
Key numbers
23.9x
trailing p/e
You are paying 23.9 times trailing earnings for a business with 100 earnings predictability. That is the price of sleep.
2.6%
dividend yield
The dividend pays 2.6% while you wait. Cash is still cash, even when the stock is pricey.
20.0%
return on capital
P&G earns 20 cents for each dollar tied up in the business. That is why it can fund brands and buybacks without drama.
$84.3B
annual revenue
That is the size of the machine. A 1% swing means about $843M.
Financial health
A++
strength
  • balance sheet grade A++ — the absolute highest — fortress balance sheet
  • risk rank 1 — safer than 95% of stocks
  • price stability 100 / 100
  • long-term debt $25.6B (6% of capital)
  • net profit margin 19.2% — keeps 19 cents of every dollar in revenue
  • return on equity 26% — $0.26 profit for every $1 investors have put in
A++ with balance sheet grade and risk rank standing out. your money faces less risk here than at most public companies.
Total return vs. market

You invested $10,000 in PG 3 years ago → it's now worth $12,610.

The index would have given you $14,540.

source: institutional data · total return
What just happened
missed estimates
P&G posted $1.88 EPS, missing Yahoo's $1.95 bar even though some coverage had $1.86.
Revenue sat at $22.4B and gross margin was 51.9%. That is steady, not hot, and the EPS miss was the part investors noticed.
$22.4B
revenue
$1.88
eps
51.9%
gross margin
the number that mattered
The $1.88 EPS print mattered because it missed the $1.95 consensus by $0.07, or 3.6%.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk here is private-label trade-down in household staples. PG can usually raise prices. the problem starts when shoppers decide store brands are good enough.

med
private-label trade-down
PG sells branded staples at a premium. if consumers get stretched, some of that pricing power leaks to cheaper alternatives.
Beauty is an $8.0B segment and one of the cleaner places to watch for softer discretionary behavior inside a $44.6B revenue base.
med
tariffs and input-cost inflation
management already flagged higher incremental tariff expenses. detergents, paper goods, and packaged consumer products do not make their own commodity pressures vanish.
an 18.7% net margin gives PG room, but the street is only looking for 2% EPS growth in fiscal 2026. there is not much slack there.
med
premium valuation for slow growth
23.9x trailing earnings is a healthy multiple for a company expected to grow sales 3% and EPS 2% next year.
if that low-single-digit plan slips, the stock can still stay safe and go nowhere. those are different things.
the combined risk is not existential. it is slower growth, tighter margins, and a premium multiple that leaves less room for disappointment than the company’s defensive image suggests.
source: institutional data · regulatory filings · risk analysis
Pay attention to
key metric
whether 3% sales growth actually shows up
that is the fiscal 2026 sales expectation in the analyst note. if PG misses a low bar, valuation becomes the story.
trend
price versus volume
recent commentary says pricing offset lower volume. that works for a while. you want to see both moving in the same direction eventually.
risk
tariff cost creep
management already flagged higher tariff expense. with EPS expected up just 2%, even small cost pressure matters.
next check-in
institutional flow
three straight quarters of net selling is not a thesis by itself, but it tells you big money is not rushing to buy this safety trade here.
Analyst rankings
short-term outlook
average
momentum score 3 — in human-speak, analysts see a steady stock, not a short-term trade.
risk profile
safest 5%
stability score 1 — lower drawdown risk than almost any stock in the market.
chart momentum
bottom 5%
technical score 5 — the business is stable, but the tape is not helping you right now.
earnings predictability
100 / 100
few companies score perfect here. the quiet part: PG is boring in exactly the way income investors usually like.
source: institutional data
Institutional activity

institutions have been net selling for 3 consecutive quarters — 1,416 buyers vs. 1,756 sellers in 4q2025. total institutional holdings: 1.6B shares. net selling for 3 quarters.

source: institutional data
Price targets
3-5 year target range
$141 $215
$164 current price
$178 target midpoint · +9% from current · 3-5yr high: $230 (+40% · 11% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
PG
xvary deep dive
pg
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it